From: Becker's GI & Endoscopy <editorial@beckershealthcare.com>
Subject: 20 states with best, worst colorectal cancer screening rates | CVS Health to purchase Aetna for $69B: 5 key notes | Oral capsule fecal microbiota transplant as effective as colonoscopy: 5 key notes | FDA approves flexible endoscope suturing system: 4 insights
Preheader:
Reply: editorial@beckershealthcare.com
View our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+ 

               
 
December 4, 2017 
Today's Top Stories
1. 20 states with the best and worst colorectal cancer screening rates 

2. Oral capsule fecal microbiota transplant as effective as colonoscopy - 5 study insights Full story 

3. CVS Health to purchase Aetna for $69B: 5 key notes Full story

4. Automated intelligence can improve clinical documentation in the ambulatory setting at the point of care. Learn more with this new white paper - click here

5. 12 new ASCs opened or announced in November Full story

6. High vs. low-volume endoscopy centers: Does it make a difference for ERCP? Full story 

7. FDA approves flexible endoscopic suturing system - 4 insights Full story
   
8. Unconscious patient's 'Do Not Resuscitate' tattoo creates ethical dilemma for ER staff Full story

9. GI leader to know: Dr. Robert Davis of Greater Houston Gastroenterology Full story

10. The AAAHC Orthopaedic Certification Experience - click here
               
                                                        
              
               
              
Channels
_____________________
Contact Us

Editorial Contact: 
Laura Dyrda   
Editor in Chief  
(312) 253-9170
email Laura

Sales, Marketing & Events:
Jessica Cole
President and CEO
______________________
 
   
Becker's ASC Review
A Becker's Healthcare Publication
17 N. State, Suite 1800| Chicago, IL 60602




Copyright © 2016. All Rights Reserved.